Ascentage Pharma Group International (AAPG) Competitors $24.43 +0.23 (+0.95%) As of 04/30/2025 04:00 PM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsHeadlinesSEC FilingsTrendsBuy This Stock AAPG vs. ROIV, RVMD, LNTH, BBIO, TGTX, TLX, LEGN, SRPT, BPMC, and NUVLShould you be buying Ascentage Pharma Group International stock or one of its competitors? The main competitors of Ascentage Pharma Group International include Roivant Sciences (ROIV), Revolution Medicines (RVMD), Lantheus (LNTH), BridgeBio Pharma (BBIO), TG Therapeutics (TGTX), Telix Pharmaceuticals Limited American Depositary Shares (TLX), Legend Biotech (LEGN), Sarepta Therapeutics (SRPT), Blueprint Medicines (BPMC), and Nuvalent (NUVL). These companies are all part of the "pharmaceutical products" industry. Ascentage Pharma Group International vs. Roivant Sciences Revolution Medicines Lantheus BridgeBio Pharma TG Therapeutics Telix Pharmaceuticals Limited American Depositary Shares Legend Biotech Sarepta Therapeutics Blueprint Medicines Nuvalent Ascentage Pharma Group International (NASDAQ:AAPG) and Roivant Sciences (NASDAQ:ROIV) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, risk, valuation, profitability, dividends, earnings, community ranking and media sentiment. Do institutionals and insiders believe in AAPG or ROIV? 64.8% of Roivant Sciences shares are held by institutional investors. 7.9% of Roivant Sciences shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Do analysts rate AAPG or ROIV? Roivant Sciences has a consensus price target of $17.50, indicating a potential upside of 50.60%. Given Roivant Sciences' higher possible upside, analysts plainly believe Roivant Sciences is more favorable than Ascentage Pharma Group International.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Ascentage Pharma Group International 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Roivant Sciences 0 Sell rating(s) 1 Hold rating(s) 2 Buy rating(s) 1 Strong Buy rating(s) 3.00 Is AAPG or ROIV more profitable? Ascentage Pharma Group International has a net margin of 0.00% compared to Roivant Sciences' net margin of -119.54%. Ascentage Pharma Group International's return on equity of 0.00% beat Roivant Sciences' return on equity.Company Net Margins Return on Equity Return on Assets Ascentage Pharma Group InternationalN/A N/A N/A Roivant Sciences -119.54%-14.05%-12.81% Does the MarketBeat Community prefer AAPG or ROIV? Roivant Sciences received 54 more outperform votes than Ascentage Pharma Group International when rated by MarketBeat users. However, 100.00% of users gave Ascentage Pharma Group International an outperform vote while only 78.57% of users gave Roivant Sciences an outperform vote. CompanyUnderperformOutperformAscentage Pharma Group InternationalOutperform Votes1100.00% Underperform VotesNo VotesRoivant SciencesOutperform Votes5578.57% Underperform Votes1521.43% Which has higher earnings & valuation, AAPG or ROIV? Roivant Sciences has lower revenue, but higher earnings than Ascentage Pharma Group International. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAscentage Pharma Group International$980.65M2.17N/AN/AN/ARoivant Sciences$122.59M67.64$4.35B-$0.15-77.47 Does the media favor AAPG or ROIV? In the previous week, Roivant Sciences had 8 more articles in the media than Ascentage Pharma Group International. MarketBeat recorded 14 mentions for Roivant Sciences and 6 mentions for Ascentage Pharma Group International. Roivant Sciences' average media sentiment score of 1.63 beat Ascentage Pharma Group International's score of 0.82 indicating that Roivant Sciences is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ascentage Pharma Group International 2 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Roivant Sciences 13 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive SummaryRoivant Sciences beats Ascentage Pharma Group International on 9 of the 14 factors compared between the two stocks. Get Ascentage Pharma Group International News Delivered to You Automatically Sign up to receive the latest news and ratings for AAPG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart AAPG vs. The Competition Export to ExcelMetricAscentage Pharma Group InternationalPharmaceutical IndustryMedical SectorNASDAQ ExchangeMarket Cap$2.13B$6.89B$5.56B$7.82BDividend YieldN/A3.05%5.11%4.22%P/E RatioN/A7.4422.5118.48Price / Sales2.17242.70395.68103.60Price / CashN/A65.8538.1834.62Price / BookN/A6.516.774.25Net IncomeN/A$143.21M$3.22B$248.23M7 Day Performance-4.20%1.98%1.45%0.89%1 Month Performance6.03%6.89%3.97%3.53%1 Year PerformanceN/A-2.52%16.14%5.08% Ascentage Pharma Group International Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)AAPGAscentage Pharma Group InternationalN/A$24.43+1.0%N/AN/A$2.13B$980.65M0.00600ROIVRoivant Sciences2.1666 of 5 stars$11.01+0.1%$17.50+58.9%+6.6%$7.86B$122.59M-73.40860Positive NewsRVMDRevolution Medicines3.7636 of 5 stars$38.77+0.5%$66.67+72.0%+8.3%$7.21B$742,000.00-10.80250Upcoming EarningsAnalyst ForecastPositive NewsLNTHLantheus3.9711 of 5 stars$101.77-1.8%$129.43+27.2%+56.8%$6.97B$1.53B16.93700Upcoming EarningsPositive NewsBBIOBridgeBio Pharma4.5498 of 5 stars$36.31+1.0%$53.00+46.0%+49.7%$6.89B$221.90M-12.74400Earnings ReportAnalyst ForecastOptions VolumeNews CoverageGap UpTGTXTG Therapeutics3.327 of 5 stars$41.33+2.6%$40.67-1.6%+233.2%$6.56B$329.00M-413.26290Upcoming EarningsNews CoveragePositive NewsGap DownTLXTelix Pharmaceuticals Limited American Depositary SharesN/A$18.80-2.2%$22.00+17.0%N/A$6.49B$783.21M0.00N/AAnalyst RevisionNews CoverageGap DownLEGNLegend Biotech2.6303 of 5 stars$34.28+0.1%$78.82+129.9%-20.1%$6.30B$627.24M-36.081,070Positive NewsSRPTSarepta Therapeutics4.678 of 5 stars$60.44-2.1%$158.70+162.6%-50.7%$5.86B$1.90B48.35840BPMCBlueprint Medicines2.5598 of 5 stars$87.66+1.8%$124.68+42.2%-2.0%$5.60B$508.82M-81.17640Analyst ForecastPositive NewsNUVLNuvalent1.891 of 5 stars$73.48-0.7%$115.50+57.2%+11.4%$5.30BN/A-21.1840Upcoming EarningsPositive News Related Companies and Tools Related Companies ROIV Alternatives RVMD Alternatives LNTH Alternatives BBIO Alternatives TGTX Alternatives TLX Alternatives LEGN Alternatives SRPT Alternatives BPMC Alternatives NUVL Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:AAPG) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | SponsoredThis isn’t a trade war. It’s worse…Investigative Journalist Bombhsell: The Curse on the U.S Dollar Depleted retirement accounts? Meme coin inv...Stansberry Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredThey rigged the gameThe U.S. fired the first shot with 145% tariffs. Apple relies heavily on Chinese production. Tesla needs Ch...Investors Alley | SponsoredTrump Treasure April 19Thanks to President Trump… A $900 investment across5 specific cryptos… Could gain 12,000% so quickly tha...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Ascentage Pharma Group International Please log in to your account or sign up in order to add this asset to your watchlist. Share Ascentage Pharma Group International With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy AAPG Stock Free AAPG Stock Alerts